Al's Comment:

 JAMA is one of the most respected journals. The  conclusion: Considering the net clinical benefit, our HRQoL (healthcare related quality of life)  data support the addition of TTFields to standard therapy in patients with glioblastoma


Posted on: 02/01/2018

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed GlioblastomaA Secondary Analysis of a Randomized Clinical Trial

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!